RecruitingNot ApplicableNCT07138677

Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial

The Safty and Efficacy of Mild Cognitiive Impairment Network Guided Transcranial Magnetic Stimulations for Patients With Early Alzheimer's Disease (SENS-eAD): A Randomized, Double-blind Trial


Sponsor

Anhui Medical University

Enrollment

40 participants

Start Date

Jul 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Estimate the safty and efficacy of personalized network neuronavigated transcranial magnetic stimulations in early Alzheimer's disease patients


Eligibility

Min Age: 45 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether transcranial magnetic stimulation (TMS) — a non-invasive brain stimulation technique — guided by a brain network map (MCI network) can slow down or improve early Alzheimer's disease symptoms. TMS uses magnetic pulses to stimulate specific brain regions involved in memory. **You may be eligible if...** - You have been diagnosed with early-stage (mild cognitive impairment or early dementia stage) Alzheimer's disease - You are within a certain age range and in generally adequate health - You are willing to undergo TMS treatment sessions **You may NOT be eligible if...** - You have metal implants in your head or body that are incompatible with magnetic stimulation (such as a cochlear implant or certain aneurysm clips) - You have a history of seizures or epilepsy - You have other significant neurological conditions - You are taking medications that significantly lower the seizure threshold Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERtranscranial magnetic stimulation

Neuronavigated Theta-Burst Transcranial Magnetic Stimulation


Locations(1)

Anhui Medical University

Hefei, Anhui, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07138677


Related Trials